Design Therapeutics, Inc.

DSGN Stock Healthcare Biotechnology
$15.11
-0.14 (-0.92%)
Price as of Aug 28, 2026 market close

Performance

1 Month
+19.7%
3 Months
+44.2%
YTD
+61.1%
1 Year
+185.6%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
78.3%
Largest decline max drawdown, since Aug 2025
-35.6%
Risk-adjusted return Sharpe ratio, 1-year
1.73

Own DSGN?

See how DSGN contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.